HArmonyCa's launch in Hong Kong marks a regional step forward for hybrid fillers that combine immediate support with longer-term biostimulatory effects.
For aesthetics teams, what matters is how the material handles in use, how consistent it is, and whether its stimulation profile fits the intended treatment goal.
In practice, that means looking beyond a single concept word and focusing on formulation quality, injection behavior, consistency, and expected tissue response.